Pfizer Total Non-Operating Income/Expense 2012-2026 | PFE
Pfizer total non-operating income/expense for the twelve months ending March 31, 2026 was $-6.631B, a 42.27% increase year-over-year.
- Pfizer annual total non-operating income/expense for 2025 was $-6.724B, a 53.24% increase from 2024.
- Pfizer annual total non-operating income/expense for 2024 was $-4.388B, a 1876.58% increase from 2023.
- Pfizer annual total non-operating income/expense for 2023 was $-0.222B, a 79.1% decline from 2022.